Evidence map›Paper›PMID 35201862›Full record

ArticleScience (New York, N.Y.)2022

Minimizing treatment-induced emergence of antibiotic resistance in bacterial infections.

Mathew Stracy, Olga Snitser, Idan Yelin, Yara Amer, Miriam Parizade, Rachel Katz, Galit Rimler, Tamar Wolf, Esma Herzel, Gideon Koren and 5 more

Open access · greenAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 101 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed, 3 pooled it
45.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 3 syntheses or guidelines pooled it, 299 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Mapping 25 years of research on gut microbiota and antibiotic resistance: bibliometric insights and future directions.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 3 countries.

Mathew StracyFaculty of Biology, Technion-Israel Institute of Technology, Haifa, Israel.ORCID 0000-0001-5685-0352
Olga SnitserFaculty of Biology, Technion-Israel Institute of Technology, Haifa, Israel.ORCID 0000-0001-6067-1912
Idan YelinFaculty of Biology, Technion-Israel Institute of Technology, Haifa, Israel.ORCID 0000-0003-2515-4113
Yara AmerFaculty of Biology, Technion-Israel Institute of Technology, Haifa, Israel.
Miriam ParizadeMaccabi Mega Lab, Maccabi Healthcare Services, Tel Aviv, Israel.
Rachel KatzMaccabi Mega Lab, Maccabi Healthcare Services, Tel Aviv, Israel.
Galit RimlerMaccabi Mega Lab, Maccabi Healthcare Services, Tel Aviv, Israel.
Tamar WolfMaccabi Mega Lab, Maccabi Healthcare Services, Tel Aviv, Israel.
Esma HerzelMaccabitech, Maccabi Healthcare Services, Tel Aviv, Israel.ORCID 0000-0003-2288-5180
Gideon KorenMaccabitech, Maccabi Healthcare Services, Tel Aviv, Israel.ORCID 0000-0002-9234-0875
Jacob KuintMaccabitech, Maccabi Healthcare Services, Tel Aviv, Israel.
Betsy FoxmanDepartment of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA.ORCID 0000-0001-6682-238X
Gabriel ChodickMaccabitech, Maccabi Healthcare Services, Tel Aviv, Israel.ORCID 0000-0002-5189-8995
Varda ShalevMaccabitech, Maccabi Healthcare Services, Tel Aviv, Israel.
Roy KishonyFaculty of Biology, Technion-Israel Institute of Technology, Haifa, Israel.ORCID 0000-0002-5013-5072
Maccabi Healthcare Services · ILTechnion – Israel Institute of Technology · ILTel Aviv University · ILUniversity of Michigan · US

Funding

The population genetics of antibiotic resistance in multi-drug environmentsR01GM081617 · NIGMS · TECHNION-ISRAEL INSTITUTE OF TECHNOLOGY · PI KISHONY, ROY · 2007 to 2018
$3.7M
European Research Council 281891NIGMS NIH HHS R01 GM081617Wellcome Trust 204684
6 · The paper itself

Abstract

Treatment of bacterial infections currently focuses on choosing an antibiotic that matches a pathogen's susceptibility, with less attention paid to the risk that even susceptibility-matched treatments can fail as a result of resistance emerging in response to treatment. Combining whole-genome sequencing of 1113 pre- and posttreatment bacterial isolates with machine-learning analysis of 140,349 urinary tract infections and 7365 wound infections, we found that treatment-induced emergence of resistance could be predicted and minimized at the individual-patient level. Emergence of resistance was common and driven not by de novo resistance evolution but by rapid reinfection with a different strain resistant to the prescribed antibiotic. As most infections are seeded from a patient's own microbiota, these resistance-gaining recurrences can be predicted using the patient's past infection history and minimized by machine learning-personalized antibiotic recommendations, offering a means to reduce the emergence and spread of resistant pathogens.

Indexed as

Drug Resistance, BacterialAlgorithmsAnti-Bacterial AgentsBacteriaBacterial InfectionsEscherichia coli InfectionsFemaleHumansMachine LearningMaleMicrobial Sensitivity TestsMicrobiotaMutationReinfectionUrinary Tract InfectionsWhole Genome SequencingAnti-Bacterial Agents

Identifiers

PMID35201862
PMCPMC7612469
OpenAlexW4213420153

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.